Cureous Labs founder Asish Mohandas took a thesis project on patient transfer and turned it into a medical device company that tested with over 300 volunteers before shipping a single product
Most medical device startups begin with a technology and then look for a problem it might solve. Cureous Labs did it the other way around.
Founded by Asish Mohandas, a mechanical engineer who completed a Masters of Design at IIT Kanpur, the company focuses on what he calls jobs to be done: identifying stubborn clinical problems first and then designing the simplest, most reliable solution that actually addresses them. The result is a startup that moves slowly by intention and ships carefully by discipline.
Where the Idea Came From
Mohandas’s journey into medical devices began with his thesis project on patient transfer. This project connected him with clinical practitioners at PGI and gave him the opportunity to learn in depth about the treatment of bedridden patients. This was followed by the opportunity to participate in the Biodesign fellowship and get early funding from grants which gave him the freedom to experiment and prototype without being pressured to secure funding from equity investors.
How the Company Builds Products
The company conducted user trials on over 300 volunteers during the product prototype phase and also incorporated clinicians into every stage of the design process. The major product of the company, the Eturnal turning system, has been designed to allow being retrofitted into existing hospital set-ups.
The company commits to on-site installation, training, and 24-hour issue resolution for clinical customers, a support model Mohandas treats as inseparable from the product itself.
Where It Is Headed
Cureous Labs is positioning itself as a long-term partner for geriatric care, targeting senior living centres, assisted-living facilities, and hospitals managing ageing populations. Mohandas sees AI and connected devices as tools that can enhance monitoring and predictive maintenance without displacing the core mission, which remains solving fundamental clinical problems that currently have no good solution.
